Literature DB >> 22542141

Recurrent implantation failure: current update and clinical approach to an ongoing challenge.

Neri Laufer1, Alex Simon.   

Abstract

A better understanding of the mechanisms responsible for implantation may improve our ability to treat RIF and improve IVF results in general. This issue's Views and Reviews aims to summarize the current knowledge on mechanisms involved in recurrent implantation failure and presents a clinical approach and potential treatments to overcome the problem.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22542141     DOI： 10.1016/j.fertnstert.2012.03.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  11 in total

1.  Genetic polymorphisms of the cobalamin transport system are associated with idiopathic recurrent implantation failure.

Authors:  Han Sung Park; Jung Oh Kim; Hui Jeong An; Chang Soo Ryu; Eun Ju Ko; Young Ran Kim; Eun Hee Ahn; Woo Sik Lee; Ji Hyang Kim; Nam Keun Kim
Journal:  J Assist Reprod Genet       Date:  2019-05-23       Impact factor: 3.412

2.  Endometrial lymphocyte concentrations in adverse reproductive outcome populations.

Authors:  Kevin Marron; Conor Harrity
Journal:  J Assist Reprod Genet       Date:  2019-03-07       Impact factor: 3.412

3.  Anti-oxidant mediated normalisation of raised intracellular cytokines in patients with reproductive failure.

Authors:  Kevin Marron; John F Kennedy; Conor Harrity
Journal:  Fertil Res Pract       Date:  2018-03-02

4.  Endometrial injury, the quality of embryos, and blastocyst transfer are the most important prognostic factors for in vitro fertilization success after previous repeated unsuccessful attempts.

Authors:  Milan Reljič; Jure Knez; Vilma Kovač; Borut Kovačič
Journal:  J Assist Reprod Genet       Date:  2017-04-06       Impact factor: 3.412

5.  The Significance of Endometrial Scratching for Clinical Pregnancy Rate in Long Agonist and Antagonist Protocols.

Authors:  Rimantas Gricius; Greta Balciuniene; Lina Jakubauskiene; Diana Ramasauskaite
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

6.  The association of AGO1 (rs595961G>A, rs636832A>G) and AGO2 (rs11996715C>A, rs2292779C>G, rs4961280C>A) polymorphisms and risk of recurrent implantation failure.

Authors:  Chang Soo Ryu; Young Ran Kim; Jung Oh Kim; Hui Jeong An; Sung Hwan Cho; Eun Hee Ahn; Ji Hyang Kim; Woo Sik Lee; Nam Keun Kim
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

7.  Peripheral CD56+CD16+ NK Cell Populations in the Early Follicular Phase Are Associated With Successful Clinical Outcomes of Intravenous Immunoglobulin Treatment in Women With Repeated Implantation Failure.

Authors:  Yao-Kai Ho; Hsiu-Hui Chen; Chun-Chia Huang; Chun-I Lee; Pin-Yao Lin; Maw-Sheng Lee; Tsung-Hsien Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-21       Impact factor: 5.555

8.  Genetic Variation of Methylenetetrahydrofolate Reductase (MTHFR) and Thymidylate Synthase (TS) Genes Is Associated with Idiopathic Recurrent Implantation Failure.

Authors:  Youngsok Choi; Jung Oh Kim; Sung Han Shim; Yubin Lee; Ji Hyang Kim; Young Joo Jeon; Jung Jae Ko; Woo Sik Lee; Nam Keun Kim
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

9.  The Relationship between Vascular Endothelial Growth Factor 1154G/A Polymorphism and Recurrent Implantation Failure.

Authors:  Laura D Vagnini; Adriana M Nascimento; Maria do Carmo T Canas; Adriana Renzi; Gabriela R Oliveira-Pelegrin; Claudia G Petersen; Ana L Mauri; João Batista A Oliveira; Ricardo L R Baruffi; Mario Cavagna; José G Franco
Journal:  Med Princ Pract       Date:  2015-08-21       Impact factor: 1.927

Review 10.  The Effects of Acupuncture on Pregnancy Outcomes of Recurrent Implantation Failure: A Systematic Review and Meta-Analysis.

Authors:  Menglin Li; Yunyun Liu; Haoran Wang; Shuzhen Zheng; Yinhe Deng; Yuemei Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-02       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.